Medication is a treatment, not a substitute
Medication-assisted treatment is an older umbrella term for using approved medication with counseling and other recovery supports. Many clinicians now use the more precise terms medications for opioid use disorder and medications for alcohol use disorder because medication is a core treatment, not an optional aid. The medication is selected for a diagnosed disorder and monitored like treatment for other chronic health conditions. Recovery goals may also include safer health, stable housing, relationships, work, and improved daily function, not only a drug test result.
Approved options depend on the substance
SAMHSA identifies methadone, buprenorphine, and naltrexone as FDA-approved medications for opioid use disorder, while naltrexone, acamprosate, and disulfiram are approved for alcohol use disorder. These medications work differently, and selection depends on the substance, health history, treatment goals, access, and patient preference. No one medication is right for every patient, and the three opioid medications have different access rules, initiation steps, and effects. Alcohol medications also differ, so a prescriber should review liver health, kidney health, pregnancy, other medicines, and the patient's preferences.
What an appointment usually covers
Care usually begins with an assessment, medication discussion, informed consent, and a plan for follow-up, dose adjustment, and side-effect monitoring. Counseling, peer support, primary care, and help with housing or employment may be offered, but access to medication should not be delayed by arbitrary counseling requirements. Follow-up should review cravings, withdrawal, substance use, side effects, mood, sleep, pain, and progress toward the patient's goals. Dose changes should be based on clinical response rather than a fixed schedule or a program's desire to end medication quickly.
Overdose risk still needs its own plan
Methadone for opioid use disorder is dispensed through certified opioid treatment programs, while buprenorphine and naltrexone can be prescribed in other qualified settings. Starting, stopping, or switching medication requires clinical guidance because timing, other medications, pregnancy, liver health, and overdose risk can affect the plan. Medication does not remove every risk, especially during treatment gaps, missed doses, or use of alcohol, benzodiazepines, fentanyl, or other opioids. Patients and close contacts should have naloxone, know how to call 911, and understand that tolerance can change.
Questions that reveal program quality
Ask which medications are available, whether the program supports long-term treatment, and how it handles missed doses or a return to opioid or alcohol use. A program that rejects approved medications without an individualized clinical reason may not be offering the full range of evidence-based care. Ask whether medication is available on the first day, whether counseling is optional or required, and how the program handles travel and pharmacy problems. Also confirm whether the provider will continue treatment during pregnancy, hospitalization, incarceration, or a transfer to another level of care.
How to start without losing time
A primary care clinician, addiction specialist, or opioid treatment program can assess options and explain expected benefits and risks. Use SAMHSA's treatment locator to find licensed services, then verify medication availability and appointment timing before relying on a listing. When calling, name the medication you want to discuss and ask for the earliest clinical assessment rather than a general admissions call. If one program has a long wait or refuses an appropriate option, contact another qualified provider while maintaining overdose precautions.
Common medication myths to challenge
Taking methadone or buprenorphine as prescribed is treatment, not evidence that a person has failed to recover. Needing medication for months or years is not automatically dependence in the harmful sense, and an arbitrary taper can increase risk when the patient is stable. Counseling can add value, but medication does not become ineffective simply because a person declines one group. Families should judge progress by safety, health, functioning, and the patient's goals rather than pressure to become medication free.